Do asthmatic smokers benefit as much as non-smokers on budesonide/ formoterol maintenance and reliever therapy? Results of an open label study

Respiratory Medicine

Volumn 106, Issue 2, 2012, Pages 189-196

  Van Schayck, Onno C P ^a   Haughney, John ^b   Aubier, Michel ^c   Selroos, Olof ^d   Ekström, Tommy ^e   Ostinelli, Juliette ^f   Buhl, Roland ^g  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

^c BICHAT HOSPITAL   (France)

^d Semeco AB   (Sweden)

^e ASTRAZENECA R AND D   (Sweden)

^f ASTRAZENECA   (United Kingdom)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

ACQ 5; Asthma; Budesonide formoterol maintenance and reliever therapy; Propensity matched controls; Smokers; Symbicort SMART

Indexed keywords

BUDESONIDE PLUS FORMOTEROL; CORTICOSTEROID; TERBUTALINE;

ADULT; AROUSAL; ARTICLE; ASTHMA; ASTHMA CONTROL QUESTIONNAIRE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; HUMAN; MAINTENANCE DRUG DOSE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; BUDESONIDE; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; ETHANOLAMINES; FEMALE; HUMANS; MALE; PEAK EXPIRATORY FLOW RATE; QUESTIONNAIRES; SMOKING; TREATMENT OUTCOME;

EID: 84655164389     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.10.017     Document Type: Article

References (27)

1. C.S. Ulrik, and P. Lange Cigarette smoking and asthma Monaldi Arch Chest Dis 56 2001 349 353 (Pubitemid 34051407)
2. V. Siroux, I. Pin, M.P. Oryszczyn, N. Le Moual, and F. Kauffmann Relationships of active smoking to asthma and asthma severity in the EGEA study Eur Respir J 15 2000 470 477 (Pubitemid 30158183)
3. R.A. Silvermann, E.D. Boudreaux, P.G. Woodruff, S. Clark, and C.A. Camargo Jr. Cigarette smoking among asthmatic adults presenting to 64 emergency departments Chest 123 2003 1472 1479 (Pubitemid 36549765)
4. C.H. Marquette, F. Saulnier, O. Leroy, B. Wallaert, C. Chopin, J.M. Demarcq, A. Durocher, and A.B. Tonnel Long-term prognosis of near-fatal asthma Am Rev Respir Dis 146 1992 76 81
5. J.M. Sippel, K. Pedula, W.M. Vollmer, S. Buist, and M.L. Osborne Associations of smoking with hospital-based care and quality of life in patients with obstructive airway disease Chest 115 1999 691 696 (Pubitemid 29129946)
6. S.E. Pedersen, E.D. Bateman, J. Bousquet, W.W. Busse, S. Yoxall, and T.J. Clark Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the gaining optimal asthma control study J Allergy Clin Immunol 120 2007 1036 1042 (Pubitemid 350029898)
7. P. Lange, J. Parner, J. Vestbo, P. Schnohr, and G. Jensen A 15-year follow-up study of ventilatory function in adults with asthma N Engl J Med 339 1998 1194 1200
8. A.L. James, L.J. Palmer, and E. Kicic Decline in lung function in the Busselton health study. The effect of asthma and cigarette smoking Am J Respir Crit Care Med 171 2005 109 114 (Pubitemid 40105408)
9. G.W. Chalmers, K.J. Macleod, S.A. Little, L.J. Thomson, C.P. McSharry, and N.C. Thomson Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma Thorax 57 2002 226 230 (Pubitemid 34214408)
10. R. Chaudhuri, E. Livingston, A.D. McMahon, L. Thomson, W. Borland, and N.C. Thomson Cigarette smoking impairs the therapeutic response to oral corticosteroids in chronic asthma Am J Respir Crit Care Med 168 2003 1308 1311 (Pubitemid 37487324)
11. J.E.M. Tomlinson, A.D. McMahon, R. Chaudhuri, J.M. Thompson, S.F. Wood, and N.C. Thomson Efficacy of low and high dose inhaled corticosteroid in smokers versus nonsmokers with mild asthma Thorax 60 2005 282 287 (Pubitemid 40522363)
12. S.C. Lazarus, V.M. Chinchilli, and N.J. Rollings Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma Am J Respir Crit Care Med 175 2007 783 790 (Pubitemid 46631789)
13. B. Pedersen, R. Dahl, R. Karlström, C.G. Peterson, and P. Venge Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking Am J Respir Crit Care Med 153 1996 1519 1529 (Pubitemid 26141335)
14. E. Livingston, N.C. Thomson, and G.W. Chalmers Impact of smoking on asthma therapy Drugs 65 2005 1521 1536
15. N.C. Thomson, M. Shepherd, M. Spears, and R. Chaudhuri Corticosteroid insensitivity in smokers with asthma: clinical evidence, mechanisms, and management Ther Respir Med 5 2006 467 481 (Pubitemid 44968304)
16. T. Ahmad, P.J. Barnes, and I.M. Adcock Overcoming steroid insensitivity in smoking asthmatics Curr Opin Invest Drugs 9 2008 470 477 (Pubitemid 351677900)
17. A. Dijkstra, J.M. Vonk, and H. Jongepier Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex Thorax 61 2006 105 110 (Pubitemid 43235425)
18. P.M. O'Byrne, C.J. Lamm, W.W. Busse, W.C. Tan, and S. Pedersen The effects of inhaled budesonide on lung function in smokers and nonsmokers with mild persistent asthma Chest 136 2009 1514 1520
19. K.L. Clearie, L. McKinlay, P.A. Williamson, and B.J. Lipworth Fluticasone/salmeterol combination confers benefits in smoking asthmatics Chest 2011 10.1378/chest.11-0392 published online June 2, 2011
20. M. Aubier, R. Buhl, and T. Ekström Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy Eur Respir J 36 2010 524 530
21. American Thoracic Society (ATS) Standards for the diagnosis and care of subjects with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 1987 225 244
22. E.F. Juniper, P.M. O'Byrne, G.H. Guyatt, P.J. Ferrie, and D.R. King Development and validation of a questionnaire to measure asthma control Eur Respir J 14 1999 902 907 (Pubitemid 29519356)
23. K. Svensson, A.C. Mörk, and E.F. Juniper ACQ. Is five out of seven items acceptable in large clinical studies? Qual Life Res 12 2003 771
24. E.F. Juniper, J. Bousquet, L. Abetz, E.D. Bateman GOAL committee Identifying 'well-controlled' and 'not well-controlled' asthma using the asthma control questionnaire Respir Med 100 2006 616 621 (Pubitemid 43285748)
25. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41 55
26. J. Haughney, M. Aubier, and L. Jørgensen Comparing asthma treatment in elderly versus younger patients Respir Med 105 2011 838 845
27. M. Aubier, J. Haughney, and O. Selroos Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen? Ther Adv Respir Dis 5 2011 289 295